At the time of writing, Edwards Lifesciences Corp [EW] stock is trading at $76.28, up 0.98%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The EW shares have gain 8.05% over the last week, with a monthly amount glided 7.57%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Edwards Lifesciences Corp [NYSE: EW] stock has seen the most recent analyst activity on April 24, 2025, when Piper Sandler upgraded its rating to a Overweight but kept the price target unchanged to $80 for it. Previously, Stifel upgraded its rating to Buy on January 30, 2025, and elevated its price target to $90. On January 16, 2025, downgrade downgraded it’s rating to Underperform but maintained its price target of $60 on the stock. BofA Securities upgraded its rating to a Buy. Jefferies downgraded its rating to Hold for this stock on September 18, 2024, and downed its price target to $70. In a note dated July 31, 2024, Daiwa Securities upgraded an Outperform rating on this stock.
For the past year, the stock price of Edwards Lifesciences Corp fluctuated between $58.93 and $95.25. Currently, Wall Street analysts expect the stock to reach $78.67 within the next 12 months. Edwards Lifesciences Corp [NYSE: EW] shares were valued at $76.28 at the most recent close of the market. An investor can expect a potential return of 3.13% based on the average EW price forecast.
Analyzing the EW fundamentals
According to Edwards Lifesciences Corp [NYSE:EW], the company’s sales were 5.54B for trailing twelve months, which represents an -11.61% plunge. Gross Profit Margin for this corporation currently stands at 0.78% with Operating Profit Margin at 0.26%, Pretax Profit Margin comes in at 0.28%, and Net Profit Margin reading is 0.73%. To continue investigating profitability, this company’s Return on Assets is posted at 0.32, Equity is 0.49 and Total Capital is 0.13. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.07.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 75.30 points at the first support level, and at 74.32 for the second support level. However, for the 1st resistance point, the stock is sitting at 76.92, and for the 2nd resistance point, it is at 77.56.
Ratios To Look Out For
It is important to note that Edwards Lifesciences Corp [NYSE:EW] has a current ratio of 4.18. In addition, the Quick Ratio stands at 3.45 and the Cash Ratio stands at 2.02. Considering the valuation of this stock, the price to sales ratio is 8.07, the price to book ratio is 4.49 and price to earnings (TTM) ratio is 30.81.
Transactions by insiders
Recent insider trading involved BOBO DONALD E JR, CVP,Strategy/Corp Development, that happened on Apr 14 ’25 when 9500.0 shares were sold. CVP, JAPAC, Lippis Daniel J. completed a deal on Apr 08 ’25 to sell 300.0 shares. Meanwhile, Officer Lippis Daniel J. bought 300.0 shares on Apr 08 ’25.
